Rufinamide vs placebo
Frequency of adverse effects ‐ dizziness ( · people with drug‐resistant focal epilepsy
Rufinamide probably leads to higher adverse effects: dizziness compared with placebo (moderate certainty).
1 finding from 1 review
- RR 2.52 [1.9, 3.34]3 studies · 1295 participantsModerate